Free Trial

RX Securities Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at RX Securities. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from RX Securities' equity research team. MarketBeat is not affiliated with or endorsed by RX Securities.

  • Updated 8/7/2017
Average Return
00.00% 12-Month ROI
Total Ratings
0 Last 12 Months
Buy Ratings
0 Last 12 Months
Sell Ratings
0 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Faron Pharmaceuticals Oy stock logo
FARN
Faron Pharmaceuticals Oy
GBX 43.25
+1.6%
1/4/2016 Initiated CoverageGBX 375BuyView details for RX Securities rating of Faron Pharmaceuticals Oy (LON:FARN) on 1/4/2016

MarketBeat's community ratings are surveys of what our community members think about RX Securities and other research firms in the last 90 days. Vote "Outperform" if you believe RX Securities's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RX Securities's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES
40 Believe will outperform S&P 500
UNDERPERFORM VOTES
38 Believe will underperform S&P 500

Best & Worst Calls